Ashwagandha for Stress and Sleep: What Clinical Trials Actually Show

News

Ashwagandha for Stress and Sleep: What Clinical Trials Actually Show

November 1, 2026 Ā· Researched and written with AI.

Ashwagandha (Withania somnifera) is one of the most widely used adaptogenic herbs in traditional wellness practices. In recent years, researchers have conducted numerous clinical trials to evaluate how standardized extracts affect everyday stress, anxiety, sleep quality, and physiological markers like serum cortisol. With a significant body of literature synthesized through 2026, systematic reviews offer a clear picture of what the clinical evidence shows.

What Clinical Trials Show for Stress and Anxiety

Multiple randomized controlled trials (RCTs) show that ashwagandha extracts can help reduce self-reported stress and anxiety scores. A 2026 systematic review analyzing clinical trial data found that ashwagandha demonstrated efficacy for anxiety across 10 RCTs and for stress across 8 RCTs, typically testing doses between 30 and 600 milligrams per day of standardized withanolide extract. A separate 2026 meta-analysis pooling 22 clinical studies reported significant statistical reductions in measured levels of stress, anxiety, and low mood among adult participants.

Individual clinical trials offer specific details on how these stress reductions present:

Sleep Quality and Fatigue

Shoppers frequently look to ashwagandha for evening relaxation and sleep support. Clinical trials indicate that improvements in sleep quality frequently accompany stress reduction.

In systematic review data, ashwagandha demonstrated positive effects on sleep outcomes across 3 randomized controlled trials. In studies measuring standardized sleep questionnaires, such as the Pittsburgh Sleep Quality Index (PSQI), participants taking ashwagandha reported better sleep quality, less fatigue, and more restorative sleep than those taking a placebo. However, researchers note that the total number of clinical trials focused primarily on sleep remains small compared to those evaluating stress and anxiety.

Biological Impact: Cortisol and Other Hormones

To understand how ashwagandha exerts its adaptogenic effects, researchers measure physiological markers of the hypothalamic-pituitary-adrenal (HPA) axis, which governs the body's stress response. Serum cortisol—a major stress hormone—is frequently evaluated.

A 2026 systematic review calculated a pooled cortisol reduction of -3.27 micrograms per deciliter (-3.27 µg/dL) across clinical trials. In addition, a comprehensive meta-analysis of 23 randomized placebo-controlled trials encompassing 1,706 adults evaluated systemic hormonal changes following oral ashwagandha supplementation. The meta-analysis confirmed a statistically significant reduction in cortisol alongside an average increase in circulating serotonin of 31.75 nanograms per milliliter (ng/mL).

The same 23-trial meta-analysis and a related 2026 endocrinology review evaluated other hormonal pathways:

Study Quality and Research Gaps

While these clinical findings are positive, systematic reviewers emphasize several study limitations:

Safety, Side Effects, and Precautions

In short- to medium-term clinical trials lasting between 30 and 84 days, ashwagandha was generally well tolerated with low rates of adverse events. However, safety researchers highlight key precautions for extended use:

Always talk to your doctor or pharmacist before starting ashwagandha, particularly if you take prescription medications (such as thyroid or blood pressure drugs), are pregnant or breastfeeding, or have an underlying liver or endocrine condition.

Sources

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This guide offers general product suggestions, not medical advice. Talk to your healthcare provider before starting supplements, especially if you are pregnant, nursing, or take medication.